Sintx Technologies Stock Today
| SINT Stock | USD 2.77 0.01 0.36% |
PerformanceOK
| Odds Of DistressQuite High
|
SINTX Technologies is selling for under 2.77 as of the 20th of July 2025; that is 0.36 percent decrease since the beginning of the trading day. The stock's last reported lowest price was 2.72. SINTX Technologies has more than 69 % chance of experiencing financial distress in the next few years of operation. However, it had a very ok returns during the last 90 days. The performance scores are derived for the period starting the 21st of April 2025 and ending today, the 20th of July 2025. Click here to learn more.
Business Domain Health Care Equipment & Services | IPO Date 13th of February 2014 | Category Healthcare | Classification Health Care |
Sintx Technologies, Inc., an advanced materials company, engages in the research, development, and commercialization of medical devices manufactured with silicon nitride for biomedical, industrial, and antipathogenic applications primarily in the United States. The company has 2.51 M outstanding shares of which 87.44 K shares are at this time shorted by private and institutional investors with about 0.44 trading days to cover. More on SINTX Technologies
Moving together with SINTX Stock
| 0.77 | DH | Definitive Healthcare | PairCorr |
| 0.71 | EW | Edwards Lifesciences Corp Earnings Call This Week | PairCorr |
| 0.84 | LH | Laboratory Earnings Call This Week | PairCorr |
Moving against SINTX Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
SINTX Stock Highlights
ESG Sustainability
Environmental | Governance | Social |
| CEO President | Eric Olson | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Old Names | [Scotia Strategic International Equity ETF Portfolio, SINTOFARM SA BUCURESTI] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Health Care Equipment & Supplies, Health Care Equipment & Services, Health Care, OMX Stockholm, NASDAQ Composite, OMX Stockholm GI, NASDAQ Health Care, Health Care, Health Care Equipment & Supplies, Medical Devices, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt LevelsSINTX Technologies can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand SINTX Technologies' financial leverage. It provides some insight into what part of SINTX Technologies' total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
SINTX Technologies (SINT) is traded on NASDAQ Exchange in USA. It is located in 1885 West 2100 South, Salt Lake City, UT, United States, 84119 and employs 20 people. SINTX Technologies is listed under Health Care Equipment & Supplies category by Fama And French industry classification. The company currently falls under 'Nano-Cap' category with a current market capitalization of 6.95 M. SINTX Technologies conducts business under Health Care Equipment & Supplies sector and is part of Health Care industry. The entity has 2.51 M outstanding shares of which 87.44 K shares are at this time shorted by private and institutional investors with about 0.44 trading days to cover.
SINTX Technologies currently holds about 4.78 M in cash with (8.64 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.09.
Check SINTX Technologies Probability Of Bankruptcy
Ownership AllocationSINTX Technologies has 11.1 % of its outstanding shares held by insiders and 4.23 % owned by institutional holders.
Check SINTX Ownership Details
SINTX Stock Institutional Holders
| Instituion | Recorded On | Shares | |
| Wells Fargo & Co | 2025-03-31 | 1.0 | |
| Goss Wealth Management Llc | 2025-03-31 | 1.0 | |
| Cornerstone Planning Group Llc | 2025-03-31 | 1.0 | |
| Advisor Group Holdings, Inc. | 2025-03-31 | 1.0 | |
| Northern Trust Investments N A | 2024-12-31 | 0.0 | |
| Citigroup Inc | 2025-03-31 | 0.0 | |
| Ubs Group Ag | 2025-03-31 | 0.0 | |
| Renaissance Technologies Corp | 2025-03-31 | 0.0 | |
| Veracity Capital Llc | 2025-06-30 | 72.5 K | |
| Heights Capital Management Inc | 2025-03-31 | 61 K | |
| Vanguard Group Inc | 2025-03-31 | 30.4 K |
SINTX Technologies Historical Income Statement
SINTX Stock Against Markets
SINTX Technologies Corporate Management
| Kevin Trask | Corporate Controller | Profile | |
| Hugh Roberts | Managing Development | Profile | |
| Ryan Bock | Chief Officer | Profile | |
| Lisa Re | Chief Officer | Profile | |
| Michael Marcroft | Vice Marketing | Profile |
Additional Tools for SINTX Stock Analysis
When running SINTX Technologies' price analysis, check to measure SINTX Technologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy SINTX Technologies is operating at the current time. Most of SINTX Technologies' value examination focuses on studying past and present price action to predict the probability of SINTX Technologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move SINTX Technologies' price. Additionally, you may evaluate how the addition of SINTX Technologies to your portfolios can decrease your overall portfolio volatility.